Introduction
============

OLT is a major cardiovascular stress both intra- and postoperatively. The ideal preoperative cardiac screening test for patients with end-stage liver disease (ESLD) has not been determined \[[@B1]\]. We evaluated the value of MUGA in predicting perioperative morbidity and mortality in patients undergoing OLT.

Methods
=======

After IRB approval we retrospectively examined the medical records of 170 ESLD patients who had MUGA scans prior to OLT from January 1994-April 1998. Morbidity was defined as reperfusion syndrome (fall in MAP \>33%), requirement for intraor postoperative inotropes, myocardial infarction (AMI), need for haemodiafiltration or ICU stay \>5 days. Mortality was restricted to 30 days. MUGA scans were defined as normal if ejection fraction (EF) was \>55% \[[@B2]\]. Analysis of results was by Chi-squared test.

Results
=======

There were 127 patients in group A (EF \>55%) and 37 patients in group B (EF \<55%). Six patients were excluded because of incomplete data. No patients had AMI. Two patients in group A died and there were no deaths in group B.

Conclusion
==========

For patients undergoing OLT, MUGA is not a useful screening test for predicting perioperative morbidity and mortality. Based upon these findings we have revised our method of pre-operative cardiac assessment of patients presenting for OLT.

  Event               Group A (No. (%))   Group B (No. (%))   *P* value
  ------------------- ------------------- ------------------- -----------
  Reperfusion         67 (53)             23 (65)             0.28
  Inotropes (intra)   42 (33)             16 (43)             0.27
  Inotropes (post)    20 (16)             9 (24)              0.24
  CVVHD               11 (9)              3 (8)               0.6
  ICU stay \>5 days   49 (38)             16 (43)             0.21
